NVO
Novo Nordisk A/S
NYSE · Healthcare · Drug Manufacturers - General · DK
$46.62
−1.87%Leverage
- Debt / equity
- 0.63x
- Net debt / equity
- 0.43x
- Debt / assets
- 0.24x
- Debt / EBITDA
- 0.77x
- Net debt / EBITDA
- 0.53x
Liquidity & coverage
- Current ratio
- 0.87x
- Quick ratio
- 0.66x
- Cash ratio
- 0.19x
- Interest coverage
- 28.43x
- EBITDA / interest
- 36.19x
- Working capital
- -$4.7B
Cash & dividend
- FCF / debt
- 0.35x
- Cash flow / debt
- 0.95x
- Dividend per share
- $1.49
- Dividend yield
- 3.2%
- Dividend growth 1y
- +21.4%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026